Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

This is a Phase II Study on the Safety and Feasibility of Identifying the Intersegmental Plane of the Lung by Iron Sucrose Injection Staining,Both on the Pleural Surface and Lung Parenchyma

NCT03516500 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT03516500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03516500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
This is a Phase II Study on the Safety and Feasibility of Identifying the Intersegmental Plane of the Lung by Iron Sucrose Injection Staining,Both on the Pleural Surface and Lung Parenchyma
Lead sponsor
Ruijin Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 9, 2018
Completion date
January 21, 2021
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung neoplasm, segmentectomy;intersegmental plane